UPB — Upstream Bio, Inc.

US Healthcare Pharma & biotech equity mkt cap 381.8M
6.97 +1.75% today
USD · as of 2026-08-21

Price · 2024-10-11 → 2026-08-21

466 daily closes shown
52w low 5.92 · high 32.60

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2024-10-11.

Performance

1 day+1.75%
1 week-1.41%
1 month+8.91%
3 months-17.61%
6 months-13.74%
Year to date-74.25%
1 year-57.40%

Technicals

RSI 1457.6
vs 50-day avg+1.78%
vs 200-day avg-52.79%
Volatility 1y90.1%
Max drawdown 1y-81.84%
Avg volume 30d568.3K
Daily bars held466
History from2024-10-11

Measured signals that fired on UPB

datesignal measured base rate
2026-06-17Cluster sale: three or more insiders
insider
-0.37% over 21 days · t = -3.38 · n = 21,542
statistically distinguishable from its control group
2026-03-19Fair value gap, bearish
structure
-0.45% over 21 days · t = -3.29 · n = 108,591
statistically distinguishable from its control group
2026-03-17Cluster sale: three or more insiders
insider
-0.37% over 21 days · t = -3.38 · n = 21,542
statistically distinguishable from its control group
2026-03-12Fair value gap, bullish
structure
-0.67% over 21 days · t = -6.43 · n = 111,973
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-06-16Sutherland Everett Rand
Chief Executive Officer
Open-market sale2.1K6.1012.8K
2026-06-16Deykin Aaron
Chief Medical Officer
Open-market sale8956.105.5K
2026-06-16GRAY MICHAEL
CFO and COO
Open-market sale8536.105.2K
2026-06-16Houghton Adam
Chief Business Officer
Open-market sale7006.104.3K
2026-06-16Ambrose Allison
General Counsel
Open-market sale4776.102.9K
2026-03-16Sutherland Everett Rand
Chief Executive Officer
Open-market sale2.1K9.2919.4K
2026-03-16Deykin Aaron
Chief Medical Officer
Open-market sale8949.298.3K
2026-03-16GRAY MICHAEL
CFO and COO
Open-market sale8529.297.9K
2026-03-16Houghton Adam
Chief Business Officer
Open-market sale6999.296.5K
2026-03-16Ambrose Allison
General Counsel
Open-market sale4759.294.4K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
FMR LLC72.9M8.1M
ORBIMED ADVISORS LLC51.2M5.7M
BlackRock, Inc.30.3M3.4M
Decheng Capital LLC24.5M2.7M
ENAVATE SCIENCES GP, LLC22.1M2.5M
VANGUARD CAPITAL MANAGEMENT LLC16.9M1.9M
Y-Intercept (Hong Kong) Ltd9.0M1.0M
FEDERATED HERMES, INC.8.8M979.8K
GEODE CAPITAL MANAGEMENT, LLC8.6M950.6K
MILLENNIUM MANAGEMENT LLC8.4M937.3K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
SCHEDULE 13G/A2026-08-12on EDGAR ↗
10-Q2026-08-112026-06-30on EDGAR ↗
8-K2026-08-112026-08-11on EDGAR ↗
SCHEDULE 13G2026-07-30on EDGAR ↗
42026-06-172026-06-16on EDGAR ↗
42026-06-172026-06-16on EDGAR ↗
42026-06-172026-06-16on EDGAR ↗
42026-06-172026-06-16on EDGAR ↗

Short selling

Avg short volume, 90d38.2% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Ask the AI about UPB

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open UPB in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →